Prognostic Significance of Epidermal Growth Factor Receptor Expression in Colon Cancer Patients Undergoing Curative Surgery-Reference-Cited by-同舟云学术

Prognostic Significance of Epidermal Growth Factor Receptor Expression in Colon Cancer Patients Undergoing Curative Surgery

Published:2006-04-18 Issue:6 Volume:13 Page:823-835
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Galizia Gennaro,Lieto Eva,Ferraraccio Francesca,De Vita Ferdinando,Castellano Paolo,Orditura Michele,Imperatore Vincenzo,Mura Anna La,Manna Giovanni La,Pinto Margherita,Catalano Giuseppe,Pignatelli Carlo,Ciardiello Fortunato

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/ASO.2006.05.052.pdf

Reference38 articles.

1. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10–30

2. Weitz J, Koch M, Debus J, Hohler T, Galle PR, Buchler MW. Colorectal cancer. Lancet 2005;365:153–65

3. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag, 2002

4. Sobrero A, Guglielmi A. Current controversies in the adjuvant therapy of colon cancer. Ann Oncol 2004;15(Suppl 4):iv39–41

5. Zaniboni A, Labianca R. Adjuvant therapy for stage II colon: an elephant in the living room? Ann Oncol 2004;15:1310–8

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging trends and therapeutic applications of monoclonal antibodies;Gene;2024-10

2. CRAC and SK Channels: Their Molecular Mechanisms Associated with Cancer Cell Development;Cancers;2022-12-23

3. Spatial heterogeneity of cancer associated protein expression in immunohistochemically stained images as an improved prognostic biomarker;Frontiers in Oncology;2022-12-19

4. Insights on the Dynamic Innovative Tumor Targeted-Nanoparticles-Based Drug Delivery Systems Activation Techniques;International Journal of Nanomedicine;2022-12

5. The Therapeutic Potential of MAPK/ERK Inhibitors in the Treatment of Colorectal Cancer;Current Cancer Drug Targets;2021-12